PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.27%
Negative revenue growth while 3088.T stands at 5.97%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.56%
Negative gross profit growth while 3088.T is at 4.07%. Joel Greenblatt would examine cost competitiveness or demand decline.
-25.71%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-29.63%
Negative operating income growth while 3088.T is at 0.81%. Joel Greenblatt would press for urgent turnaround measures.
-26.28%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-26.27%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-26.27%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.00%
Share change of 0.00% while 3088.T is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.93%
10Y revenue/share CAGR 1.25-1.5x 3088.T's 53.32%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
66.65%
5Y revenue/share CAGR above 1.5x 3088.T's 25.80%. David Dodd would look for consistent product or market expansions fueling outperformance.
33.46%
3Y revenue/share CAGR above 1.5x 3088.T's 16.76%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41.85%
Below 50% of 3088.T's 147.42%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
40.83%
Below 50% of 3088.T's 148.00%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-8.53%
Negative 3Y CAGR while 3088.T is 56.48%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
126.08%
5Y equity/share CAGR above 1.5x 3088.T's 46.26%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
59.09%
3Y equity/share CAGR above 1.5x 3088.T's 24.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-9.09%
Negative 5Y dividend/share CAGR while 3088.T stands at 133.33%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
42.86%
3Y dividend/share CAGR at 75-90% of 3088.T's 55.56%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
67.36%
AR growth well above 3088.T's 16.15%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.88%
We show growth while 3088.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.82%
Asset growth well under 50% of 3088.T's 5.17%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.86%
75-90% of 3088.T's 3.31%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-4.54%
We’re deleveraging while 3088.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
2.21%
SG&A declining or stable vs. 3088.T's 5.68%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.